SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

ETR:1SXP Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	24.88	22.47	23.18	24.36	28.8	27.86
Short-Term Investments	-	3.2	3.25	1.53	1.49	-
Cash & Short-Term Investments	24.88	25.67	26.43	25.89	30.28	27.86
Cash Growth	-12.06%	-2.89%	2.09%	-14.51%	8.71%	49.73%
Accounts Receivable	298.89	281.1	225.45	223.7	199.05	150.94
Other Receivables	7.39	32.41	33.73	29.71	28.65	15.76
Receivables	486.15	469.49	401.27	289.69	390.26	187.13
Inventory	171.86	174.98	146.26	138.94	128.94	83.52
Prepaid Expenses	-	2.55	2.77	3.13	2.94	1.88
Other Current Assets	38.64	8.72	7.51	10.69	2.1	1.77
Total Current Assets	721.52	681.4	584.25	468.34	554.52	302.16
Property, Plant & Equipment	832.51	785.67	723.49	637.81	517.21	334.14
Long-Term Investments	95.97	88.5	85.06	79.07	79.83	62.26
Goodwill	-	28.43	29.35	29.49	30.95	29.33
Other Intangible Assets	30.86	1.26	1.12	1.45	1.92	1.72
Long-Term Deferred Tax Assets	13.51	13.04	14.33	14.83	11.75	10.11
Other Long-Term Assets	0.09	0.34	0.32	0.84	0.33	0.18
Total Assets	1,694	1,599	1,438	1,232	1,197	739.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	77.72	103.88	95.51	90.64	99.6	63.38
Accrued Expenses	56.32	44.55	42.43	52.86	46.58	39
Short-Term Debt	231.33	219.95	200.54	137.47	120.57	96.98
Current Portion of Leases	-	3.81	4.93	3.14	3.38	1.39
Current Income Taxes Payable	15.74	22.5	35.33	20.4	12.65	16.3
Current Unearned Revenue	28.07	26.98	24.3	20.5	14.76	8.84
Other Current Liabilities	39.98	32.18	32.45	26.14	25.49	18.32
Total Current Liabilities	449.16	453.85	435.48	351.15	323.02	244.21
Long-Term Leases	-	79.2	80.87	69.19	71.43	2.21
Long-Term Unearned Revenue	112.19	116.7	78.61	66.14	39.95	19.85
Pension & Post-Retirement Benefits	20.41	23.57	27.2	18.78	14.63	34.16
Long-Term Deferred Tax Liabilities	22.01	21.99	19.94	24.82	20.7	11.75
Other Long-Term Liabilities	92.33	9.58	7.32	9.57	17.73	8.3
Total Liabilities	696.1	704.9	649.42	539.65	487.46	320.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	150.62	150.62	150.62	150.62	-	-
Comprehensive Income & Other	845.53	741.17	636.01	539.82	707.28	417.96
Total Common Equity	996.15	891.78	786.63	690.43	707.28	417.96
Minority Interest	2.21	1.97	1.86	1.75	1.77	1.46
Shareholders' Equity	998.35	893.75	788.49	692.18	709.04	419.42
Total Liabilities & Equity	1,694	1,599	1,438	1,232	1,197	739.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	231.33	302.97	286.34	209.81	195.38	100.58
Net Cash (Debt)	-206.45	-277.3	-259.91	-183.92	-165.09	-72.72
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.37	-1.84	-1.73	-1.22	-1.10	-0.48
Filing Date Shares Outstanding	149.34	150.61	150.61	150.61	150.61	150.61
Total Common Shares Outstanding	149.34	150.61	150.61	150.61	150.61	150.61
Working Capital	272.36	227.55	148.77	117.19	231.5	57.95
Book Value Per Share	6.67	5.92	5.22	4.58	4.70	2.78
Tangible Book Value	965.29	862.09	756.16	659.49	674.41	386.91
Tangible Book Value Per Share	6.46	5.72	5.02	4.38	4.48	2.57
Land	-	357.5	336.47	260.95	240.49	143.56
Machinery	-	812.35	730.55	615.67	565.37	443.39
Construction In Progress	-	205.07	192.49	250.62	173.47	122.12

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error